• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYB
Click for more information
4.41% $2.17

CYBG PLC - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CYB Transactions by Directors and PDMR11/02/16
CYB Court Confirmation of Reduction of Capital11/02/16
CYB Daily Stabilisation Activity Report10/02/16
CYB Transactions By Directors & PDMR10/02/16
CYB Fitch Rating Update10/02/16
CYB Issued Capital - Other09/02/16
CYB Publication of Prospectus09/02/16
CYB Standard & Poor's Rating Update09/02/16
CYB Admission to Trading - London Stock Exchange08/02/16
CYB Daily Stabilisation Acitivity Report08/02/16
CYB CYBG Announcement re Moody's Rating Update05/02/16
CYB Daily Stabilisation Activity Report05/02/16
CYB Capital Structure and Terms Applicable to CYBG Securities04/02/16
CYB Information Form and Checklist Annexure I04/02/16
CYB Information Form and Checklist - ASX Foreign Exempt Listing04/02/16
CYB ASX Announcement - Commencement of Trading of CDIs04/02/16
CYB LSE - Prospectus Announcement04/02/16
CYB LSE - Pricing Announcement04/02/16
CYB Articles of Association04/02/16
CYB ASX Market Release - Admission to the Official ListPRICE SENSITIVE04/02/16
CYB Daily Stabilisation Activity Report04/02/16
CYB ASX Appendix 1C - ASX Foreign Exempt Listing Application04/02/16
CYB Prospectus04/02/16
CYB ASX Notice - Admission and Quotation Update03/02/16
CYB Transactions by Directors and PDMR
11/02/16
CYB Court Confirmation of Reduction of Capital
11/02/16
CYB Daily Stabilisation Activity Report
10/02/16
CYB Transactions By Directors & PDMR
10/02/16
CYB Fitch Rating Update
10/02/16
CYB Issued Capital - Other
09/02/16
CYB Publication of Prospectus
09/02/16
CYB Standard & Poor's Rating Update
09/02/16
CYB Admission to Trading - London Stock Exchange
08/02/16
CYB Daily Stabilisation Acitivity Report
08/02/16
CYB CYBG Announcement re Moody's Rating Update
05/02/16
CYB Daily Stabilisation Activity Report
05/02/16
CYB Capital Structure and Terms Applicable to CYBG Securities
04/02/16
CYB Information Form and Checklist Annexure I
04/02/16
CYB Information Form and Checklist - ASX Foreign Exempt Listing
04/02/16
CYB ASX Announcement - Commencement of Trading of CDIs
04/02/16
CYB LSE - Prospectus Announcement
04/02/16
CYB LSE - Pricing Announcement
04/02/16
CYB Articles of Association
04/02/16
CYB ASX Market Release - Admission to the Official List
04/02/16PRICE SENSITIVE
CYB Daily Stabilisation Activity Report
04/02/16
CYB ASX Appendix 1C - ASX Foreign Exempt Listing Application
04/02/16
CYB Prospectus
04/02/16
CYB ASX Notice - Admission and Quotation Update
03/02/16
refresh Created with Sketch. REFRESH
 

Top Stories

Tambourah chases gold veins and mineralisation extension with drilling

Tambourah Metals Ltd has discovered two high-grade gold veins through a diamond drilling program in Western Australia
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.